Dare Bioscience, Inc.
DARE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401914
No open-market purchases or sales by Dare Bioscience, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.75M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Dare Bioscience, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 28 | 1 | 22 | −5 |
| SharesConverted for a 1-for-12 split | 601.4K | 17.0K | 655.4K | +70.9K (+12.1%) |
| Value | $2.46M | $68.4K | $2.08M | −$309.5K (−13.0%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Dare Bioscience, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 16,971 | $55.0K | 0.00% |
| Founders Financial Securities LLC | 11,586 | $37.5K | 0.00% |
| Price T Rowe Associates Inc | 10,491 | $34.0K | 0.00% |
| Bryn Mawr Trust Co | 71 | $230 | 0.00% |
| EverSource Wealth Advisors, LLC | 42 | $136 | 0.00% |
| Planning Capital Management Corp | 9 | $30 | 0.00% |
Sold out (11)
Institutions that held Dare Bioscience, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Two Sigma Securities, LLC | 102,896 | $34.6K |
| Susquehanna International Group, LLP | 34,958 | $11.7K |
| Wealth Enhancement Advisory Services, LLC | 30,875 | $10.4K |
| Charles Schwab Investment Management Inc | 30,532 | $10.3K |
| Bank of New York Mellon Corp | 25,947 | $8.72K |
| Raymond James Financial Services Advisors, Inc. | 20,000 | $6.72K |
| Advisor Group Holdings, Inc. | 20,000 | $6.72K |
| Jane Street Group, LLC | 11,145 | $3.75K |
| Cerity Partners LLC | 10,000 | $3.36K |
| The PNC Financial Services Group, Inc. | 3,000 | $1.01K |
| FMR LLC | 503 | $169 |
Not filed for Q3 2024 yet (1)
Institutions that held Dare Bioscience, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 203,632 | $68.4K |